Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease
The precise assessment of liver fibrosis degree is imperative for monitoring and managing chronic liver diseases. Traditionally, liver biopsy and quantitative blood biomarkers have been the mainstays for fibrosis assessment, albeit each with its inherent limitations. However, the emergence of elasto...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2024-04-01
|
| Series: | Archives of Medical Science |
| Subjects: | |
| Online Access: | https://www.archivesofmedicalscience.com/Progress-and-prospects-of-elastography-techniques-in-the-evaluation-of-fibrosis-in,187079,0,2.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832584826838843392 |
|---|---|
| author | Yang Wang Xiaohuan Yang Sisi Wang |
| author_facet | Yang Wang Xiaohuan Yang Sisi Wang |
| author_sort | Yang Wang |
| collection | DOAJ |
| description | The precise assessment of liver fibrosis degree is imperative for monitoring and managing chronic liver diseases. Traditionally, liver biopsy and quantitative blood biomarkers have been the mainstays for fibrosis assessment, albeit each with its inherent limitations. However, the emergence of elastography presents a promising non-invasive alternative, potentially supplanting or complementing traditional biomarkers. In contrast to conventional biomarkers, elastography offers several advantages. Firstly, it is non-invasive, sidestepping the risks and discomfort associated with liver biopsy. Secondly, this technique provides real-time and intuitive fibrosis assessments, characterized by user-friendly operation and high reproducibility. Thirdly, elastography excels in diagnosing moderate to severe fibrosis, is vital for determining treatment strategies and monitoring disease progression. Notably, MRE stands out as the most accurate non-invasive method for fibrosis assessment, especially suitable for advanced fibrotic stages. This article provides an overview of the advancements in elastography as a viable quantitative biomarker for chronic liver disease fibrosis burden. |
| format | Article |
| id | doaj-art-e18c2f9f0da2467ab0fbacf203bf96f0 |
| institution | Kabale University |
| issn | 1734-1922 1896-9151 |
| language | English |
| publishDate | 2024-04-01 |
| publisher | Termedia Publishing House |
| record_format | Article |
| series | Archives of Medical Science |
| spelling | doaj-art-e18c2f9f0da2467ab0fbacf203bf96f02025-01-27T10:45:12ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512024-04-012061784179210.5114/aoms/187079187079Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver diseaseYang Wang0Xiaohuan Yang1Sisi Wang2Department of Ultrasound, Shandong Public Health Clinical Center, Jinan, Shandong, ChinaDepartment of Ultrasound, Central Hospital Affiliated To Shandong First Medical University, Jinan, Shandong, ChinaDepartment of Ultrasound, Shandong Public Health Clinical Center, Jinan, Shandong, ChinaThe precise assessment of liver fibrosis degree is imperative for monitoring and managing chronic liver diseases. Traditionally, liver biopsy and quantitative blood biomarkers have been the mainstays for fibrosis assessment, albeit each with its inherent limitations. However, the emergence of elastography presents a promising non-invasive alternative, potentially supplanting or complementing traditional biomarkers. In contrast to conventional biomarkers, elastography offers several advantages. Firstly, it is non-invasive, sidestepping the risks and discomfort associated with liver biopsy. Secondly, this technique provides real-time and intuitive fibrosis assessments, characterized by user-friendly operation and high reproducibility. Thirdly, elastography excels in diagnosing moderate to severe fibrosis, is vital for determining treatment strategies and monitoring disease progression. Notably, MRE stands out as the most accurate non-invasive method for fibrosis assessment, especially suitable for advanced fibrotic stages. This article provides an overview of the advancements in elastography as a viable quantitative biomarker for chronic liver disease fibrosis burden.https://www.archivesofmedicalscience.com/Progress-and-prospects-of-elastography-techniques-in-the-evaluation-of-fibrosis-in,187079,0,2.htmlelastographychronic liver diseasefibrosisbiomarkers |
| spellingShingle | Yang Wang Xiaohuan Yang Sisi Wang Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease Archives of Medical Science elastography chronic liver disease fibrosis biomarkers |
| title | Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease |
| title_full | Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease |
| title_fullStr | Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease |
| title_full_unstemmed | Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease |
| title_short | Progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease |
| title_sort | progress and prospects of elastography techniques in the evaluation of fibrosis in chronic liver disease |
| topic | elastography chronic liver disease fibrosis biomarkers |
| url | https://www.archivesofmedicalscience.com/Progress-and-prospects-of-elastography-techniques-in-the-evaluation-of-fibrosis-in,187079,0,2.html |
| work_keys_str_mv | AT yangwang progressandprospectsofelastographytechniquesintheevaluationoffibrosisinchronicliverdisease AT xiaohuanyang progressandprospectsofelastographytechniquesintheevaluationoffibrosisinchronicliverdisease AT sisiwang progressandprospectsofelastographytechniquesintheevaluationoffibrosisinchronicliverdisease |